Abstract
Studies in murine experimental Leishmania major infection have helped to understand the requirements for efficient development of T helper (Th)1/cytotoxic T (Tc)1-mediated protection against the parasite. As such they have revealed that Fcγ receptor (FcγR)I and Fcγ RIII-mediated uptake of L. major amastigotes by dendritic cells (DC) is an important prerequisite for Th1 development. In addition, DC-derived cytokines contribute to adequate T-cell education. DC-based vaccines may thus provide an important tool for both the development of a prophylactic vaccine against leishmaniasis and - together with leishmanicidal drugs - for eliciting immune-deviating functions towards protective immunity in non-healing leishmaniasis. This review highlights recent advances in the understanding of the role of DC for the induction of Th1/Tc1-predominant immunity against L. major and how this knowledge may translate into clinical approaches. © 2007 The Authors Journal compilation 2007 Blackwell Munksgaard.
Author supplied keywords
Cite
CITATION STYLE
Von Stebut, E. (2007). Cutaneous Leishmania infection: Progress in pathogenesis research and experimental therapy. Experimental Dermatology, 16(4), 340–346. https://doi.org/10.1111/j.1600-0625.2007.00554.x
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.